153 related articles for article (PubMed ID: 11920221)
1. HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand.
Gillespie G; Mutis T; Schrama E; Kamp J; Esendam B; Falkenburg JF; Goulmy E; Moss P
Hematol J; 2000; 1(6):403-10. PubMed ID: 11920221
[TBL] [Abstract][Full Text] [Related]
2. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
Mutis T; Blokland E; Kester M; Schrama E; Goulmy E
Blood; 2002 Jul; 100(2):547-52. PubMed ID: 12091347
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.
Mutis T; Verdijk R; Schrama E; Esendam B; Brand A; Goulmy E
Blood; 1999 Apr; 93(7):2336-41. PubMed ID: 10090944
[TBL] [Abstract][Full Text] [Related]
4. Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
Mutis T; Ghoreschi K; Schrama E; Kamp J; Heemskerk M; Falkenburg JH; Wilke M; Goulmy E
Biol Blood Marrow Transplant; 2002; 8(8):412-9. PubMed ID: 12234166
[TBL] [Abstract][Full Text] [Related]
5. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
6. Exclusive TCRVbeta chain usage of ex vivo generated minor Histocompatibility antigen HA-1 specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping.
Verdijk RM; Mutis T; Wilke M; Pool J; Schrama E; Brand A; Goulmy E
Hematol J; 2002; 3(6):271-5. PubMed ID: 12522448
[TBL] [Abstract][Full Text] [Related]
7. Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Oosten LE; Blokland E; van Halteren AG; Curtsinger J; Mescher MF; Falkenburg JH; Mutis T; Goulmy E
Blood; 2004 Jul; 104(1):224-6. PubMed ID: 15031203
[TBL] [Abstract][Full Text] [Related]
8. Induction of minor histocompatiblity antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation.
Brossart P; Spahlinger B; Grünebach F; Stuhler G; Reichardt VL; Kanz L; Brugger
Blood; 1999 Dec; 94(12):4374-6. PubMed ID: 10636695
[No Abstract] [Full Text] [Related]
9. Identification of a graft versus host disease-associated human minor histocompatibility antigen.
den Haan JM; Sherman NE; Blokland E; Huczko E; Koning F; Drijfhout JW; Skipper J; Shabanowitz J; Hunt DF; Engelhard VH
Science; 1995 Jun; 268(5216):1476-80. PubMed ID: 7539551
[TBL] [Abstract][Full Text] [Related]
10. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.
Kloosterboer FM; van Luxemburg-Heijs SA; van Soest RA; Barbui AM; van Egmond HM; Strijbosch MP; Kester MG; Marijt WA; Goulmy E; Willemze R; Falkenburg JH
Leukemia; 2004 Apr; 18(4):798-808. PubMed ID: 14973499
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
Schilbach K; Kerst G; Walter S; Eyrich M; Wernet D; Handgretinger R; Xie W; Rammensee HG; Müller I; Bühring HJ; Niethammer D
Blood; 2005 Jul; 106(1):144-9. PubMed ID: 15731181
[TBL] [Abstract][Full Text] [Related]
12. General T-cell receptor antagonists to immunomodulate HLA-A2-restricted minor histocompatibility antigen HA-1-specific T-cell responses.
den Haan JM; Mutis T; Blokland E; IJzerman AP; Goulmy E
Blood; 2002 Feb; 99(3):985-92. PubMed ID: 11807003
[TBL] [Abstract][Full Text] [Related]
13. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1.
Mommaas B; Stegehuis-Kamp JA; van Halteren AG; Kester M; Enczmann J; Wernet P; Kögler G; Mutis T; Brand A; Goulmy E
Blood; 2005 Feb; 105(4):1823-7. PubMed ID: 15498856
[TBL] [Abstract][Full Text] [Related]
14. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.
Heemskerk MH; Hoogeboom M; de Paus RA; Kester MG; van der Hoorn MA; Goulmy E; Willemze R; Falkenburg JH
Blood; 2003 Nov; 102(10):3530-40. PubMed ID: 12869497
[TBL] [Abstract][Full Text] [Related]
15. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens.
Dickinson AM; Wang XN; Sviland L; Vyth-Dreese FA; Jackson GH; Schumacher TN; Haanen JB; Mutis T; Goulmy E
Nat Med; 2002 Apr; 8(4):410-4. PubMed ID: 11927949
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Falkenburg JH; Goselink HM; van der Harst D; van Luxemburg-Heijs SA; Kooy-Winkelaar YM; Faber LM; de Kroon J; Brand A; Fibbe WE; Willemze R
J Exp Med; 1991 Jul; 174(1):27-33. PubMed ID: 2056279
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
Warren EH; Greenberg PD; Riddell SR
Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709
[TBL] [Abstract][Full Text] [Related]
18. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
Hudecek M; Bartsch K; Tschiedel S; Niederwieser D
Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1511-6. PubMed ID: 18597211
[TBL] [Abstract][Full Text] [Related]
19. Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells.
Eiz-Vesper B; Horn PA; Daubert C; Khattab B; Blasczyk R
Transfusion; 2006 Jul; 46(7):1210-20. PubMed ID: 16836569
[TBL] [Abstract][Full Text] [Related]
20. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
